MANILA, Philippines — Department of Science and Technology (DOST) Secretary Fortunato Dela Peña on Saturday said the Food and Drug Administration (FDA) has approved the clinical trials for “lagundi” (Vitex negundo) also known as the Chinese chaste tree as a supplemental treatment against the coronavirus disease (COVID-19).
“Yung pong sa lagundi ay good news po ay inaprubahan ng ng FDA ang clinical trials,” Dela Peña said during the Laging Handa press briefing.
(Good news, lagundi has been approved by the FDA for clinical trials.)
“So ito lang, early this week po naaprubahan (It was approved earlier this week),” he added.
According to Dela Peña, the clinical trials for lagundi will be participated by COVID-19 patients having mild symptoms, and are admitted in three quarantine centers: the Quezon Institute quarantine center, Sta. Ana Hospital, and Philippine National Police-National Capital